1. Kong XH, Zhou LZ. Study progress of giant knotweed rhizome. Guiding J Tradit Chin Med Pharm (Chin) 2009;15(5):107–110.
2. Gao SH, Yang SL, Fan GR. Study progress of polydatin. J Pharmaceutical Practice (Chin) 2005;23(5):145–147.
3. Das S, Das DK. Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov 2007;2:133–138.
4. Zhang LP, Yang CY, Wang YP, Guan Y, Xu Y, Zhang Y. ATP-sensitive potassium channel and mitochondrial permeability transition pore involve in cardioprotection of polydatin. Chin J Pharm Toxicol (Chin) 2009;32:81–88.
5. Zhao J, Li HY, Wang ZH, Tong CQ. Effect of polydatin on ultrastructure of cardiac myocytes in rats with adriamycin-induced myocardial damage. Acta Acad Med CPAPF (Chin) 2010;19:629–630,shift 634.